Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
Total |
Common Stock and Capital in Excess of Par Value, Shares |
Common Stock and Capital in Excess of Par Value, Amount |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Total KLA Stockholders’ Equity |
Non-Controlling Interest |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Balance as of July 1, 2018 |
|
|
$ 617,999
|
|
|
|
|
Balance (in shares) at Jun. 30, 2018 |
|
156,048
|
|
|
|
|
|
Balance at Jun. 30, 2018 |
$ 1,620,511
|
|
617,999
|
$ 1,056,445
|
$ (53,933)
|
$ 1,620,511
|
$ 0
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Reclassification of stranded tax effects |
|
|
|
10,920
|
(10,920)
|
|
|
Balance (in shares) at Jun. 30, 2018 |
|
156,048
|
|
|
|
|
|
Balance at Jun. 30, 2018 |
1,620,511
|
|
617,999
|
1,056,445
|
(53,933)
|
1,620,511
|
0
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
395,944
|
|
|
395,944
|
|
395,944
|
|
Other comprehensive income (loss) |
8,611
|
|
|
|
8,611
|
8,611
|
|
Net issuance under employee stock plans (in shares) |
|
332
|
|
|
|
|
|
Net issuance under employee stock plans |
(26,961)
|
|
(26,961)
|
|
|
(26,961)
|
|
Repurchase of common stock (in shares) |
|
(2,781)
|
|
|
|
|
|
Repurchase of common stock |
(307,787)
|
|
(11,010)
|
(296,777)
|
|
(307,787)
|
|
Cash dividends and dividend equivalents declared |
(117,947)
|
|
|
(117,947)
|
|
(117,947)
|
|
Stock-based compensation expense |
16,138
|
|
16,138
|
|
|
16,138
|
|
Balance (in shares) at Sep. 30, 2018 |
|
153,599
|
|
|
|
|
|
Balance at Sep. 30, 2018 |
1,567,369
|
|
596,166
|
1,027,370
|
(56,167)
|
1,567,369
|
0
|
Balance (in shares) at Jun. 30, 2018 |
|
156,048
|
|
|
|
|
|
Balance at Jun. 30, 2018 |
1,620,511
|
|
617,999
|
1,056,445
|
(53,933)
|
1,620,511
|
0
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
957,772
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(4,129)
|
|
|
|
|
|
|
Net loss attributable to non-controlling interest |
(83)
|
|
|
|
|
|
|
Repurchase of common stock (in shares) |
|
(7,107)
|
|
|
|
|
|
Repurchase of common stock |
(756,204)
|
|
|
|
|
|
|
Balance (in shares) at Mar. 31, 2019 |
|
161,912
|
|
|
|
|
|
Balance at Mar. 31, 2019 |
2,885,588
|
|
1,989,914
|
928,086
|
(68,907)
|
2,849,093
|
36,495
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Adoption of ASC 606 | Accounting Standards Update 2014-09 |
(21,140)
|
|
|
(21,215)
|
75
|
(21,140)
|
|
Balance as of July 1, 2018 |
1,599,371
|
|
|
1,046,150
|
(64,778)
|
1,599,371
|
0
|
Balance (in shares) at Sep. 30, 2018 |
|
153,599
|
|
|
|
|
|
Balance at Sep. 30, 2018 |
1,567,369
|
|
596,166
|
1,027,370
|
(56,167)
|
1,567,369
|
0
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
369,100
|
|
|
369,100
|
|
369,100
|
|
Other comprehensive income (loss) |
(14,280)
|
|
|
|
(14,280)
|
(14,280)
|
|
Net issuance under employee stock plans (in shares) |
|
321
|
|
|
|
|
|
Net issuance under employee stock plans |
17,323
|
|
17,323
|
|
|
17,323
|
|
Repurchase of common stock (in shares) |
|
(2,556)
|
|
|
|
|
|
Repurchase of common stock |
(242,401)
|
|
(9,919)
|
(232,482)
|
|
(242,401)
|
|
Cash dividends and dividend equivalents declared |
(115,184)
|
|
|
(115,184)
|
|
(115,184)
|
|
Stock-based compensation expense |
15,695
|
|
15,695
|
|
|
15,695
|
|
Balance (in shares) at Dec. 31, 2018 |
|
151,364
|
|
|
|
|
|
Balance at Dec. 31, 2018 |
1,597,622
|
|
619,265
|
1,048,804
|
(70,447)
|
1,597,622
|
0
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
192,728
|
|
|
192,728
|
|
192,728
|
|
Other comprehensive income (loss) |
1,540
|
|
|
|
1,540
|
1,540
|
|
Net loss attributable to non-controlling interest |
(83)
|
|
|
|
|
|
(83)
|
Assumption of stock-based compensation plan awards in connection with the acquisition of Orbotech |
13,281
|
|
13,281
|
|
|
13,281
|
|
Common stock issued upon the acquisition of Orbotech (in shares) |
|
12,292
|
|
|
|
|
|
Common stock issued upon the acquisition of Orbotech |
1,330,786
|
|
1,330,786
|
|
|
1,330,786
|
|
Net issuance under employee stock plans (in shares) |
|
26
|
|
|
|
|
|
Net issuance under employee stock plans |
(371)
|
|
(371)
|
|
|
(371)
|
|
Repurchase of common stock (in shares) |
|
(1,770)
|
|
|
|
|
|
Repurchase of common stock |
(206,017)
|
|
(7,240)
|
(198,777)
|
|
(206,017)
|
|
Cash dividends and dividend equivalents declared |
(114,669)
|
|
|
(114,669)
|
|
(114,669)
|
|
Non-controlling interest in connection with the acquisition of Orbotech |
36,578
|
|
|
|
|
|
36,578
|
Stock-based compensation expense |
34,193
|
|
34,193
|
|
|
34,193
|
|
Balance (in shares) at Mar. 31, 2019 |
|
161,912
|
|
|
|
|
|
Balance at Mar. 31, 2019 |
2,885,588
|
|
1,989,914
|
928,086
|
(68,907)
|
2,849,093
|
36,495
|
Balance (in shares) at Jun. 30, 2019 |
|
159,475
|
|
|
|
|
|
Balance at Jun. 30, 2019 |
2,677,693
|
|
2,017,312
|
714,825
|
(73,029)
|
2,659,108
|
18,585
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
346,525
|
|
|
346,525
|
|
346,525
|
|
Other comprehensive income (loss) |
1,174
|
|
|
|
1,174
|
1,174
|
|
Net loss attributable to non-controlling interest |
(129)
|
|
|
|
|
|
(129)
|
Net issuance under employee stock plans (in shares) |
|
281
|
|
|
|
|
|
Net issuance under employee stock plans |
(23,423)
|
|
(23,423)
|
|
|
(23,423)
|
|
Repurchase of common stock (in shares) |
|
(1,659)
|
|
|
|
|
|
Repurchase of common stock |
(228,496)
|
|
(20,988)
|
(207,508)
|
|
(228,496)
|
|
Cash dividends and dividend equivalents declared |
(120,669)
|
|
|
(120,669)
|
|
(120,669)
|
|
Stock-based compensation expense |
26,944
|
|
26,944
|
|
|
26,944
|
|
Balance (in shares) at Sep. 30, 2019 |
|
158,097
|
|
|
|
|
|
Balance at Sep. 30, 2019 |
2,679,619
|
|
1,999,845
|
733,173
|
(71,855)
|
2,661,163
|
18,456
|
Balance (in shares) at Jun. 30, 2019 |
|
159,475
|
|
|
|
|
|
Balance at Jun. 30, 2019 |
2,677,693
|
|
2,017,312
|
714,825
|
(73,029)
|
2,659,108
|
18,585
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
805,532
|
|
|
|
|
|
|
Other comprehensive income (loss) |
(15,265)
|
|
|
|
|
|
|
Net loss attributable to non-controlling interest |
(822)
|
|
|
|
|
|
|
Repurchase of common stock (in shares) |
|
(5,326)
|
|
|
|
|
|
Repurchase of common stock |
(821,084)
|
|
|
|
|
|
|
Balance (in shares) at Mar. 31, 2020 |
|
155,049
|
|
|
|
|
|
Balance at Mar. 31, 2020 |
2,325,196
|
|
2,019,071
|
376,656
|
(88,294)
|
2,307,433
|
17,763
|
Balance (in shares) at Sep. 30, 2019 |
|
158,097
|
|
|
|
|
|
Balance at Sep. 30, 2019 |
2,679,619
|
|
1,999,845
|
733,173
|
(71,855)
|
2,661,163
|
18,456
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
380,555
|
|
|
380,555
|
|
380,555
|
|
Other comprehensive income (loss) |
5,097
|
|
|
|
5,097
|
5,097
|
|
Net loss attributable to non-controlling interest |
(250)
|
|
|
|
|
|
(250)
|
Net issuance under employee stock plans (in shares) |
|
442
|
|
|
|
|
|
Net issuance under employee stock plans |
12,262
|
|
12,262
|
|
|
12,262
|
|
Repurchase of common stock (in shares) |
|
(1,690)
|
|
|
|
|
|
Repurchase of common stock |
(280,593)
|
|
(21,375)
|
(259,218)
|
|
(280,593)
|
|
Cash dividends and dividend equivalents declared |
(135,509)
|
|
|
(135,509)
|
|
(135,509)
|
|
Stock-based compensation expense |
26,789
|
|
26,789
|
|
|
26,789
|
|
Balance (in shares) at Dec. 31, 2019 |
|
156,849
|
|
|
|
|
|
Balance at Dec. 31, 2019 |
2,687,970
|
|
2,017,521
|
719,001
|
(66,758)
|
2,669,764
|
18,206
|
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
78,452
|
|
|
78,452
|
|
78,452
|
|
Other comprehensive income (loss) |
(21,536)
|
|
|
|
(21,536)
|
(21,536)
|
|
Net loss attributable to non-controlling interest |
(443)
|
|
|
|
|
|
(443)
|
Net issuance under employee stock plans (in shares) |
|
177
|
|
|
|
|
|
Net issuance under employee stock plans |
(4,284)
|
|
(4,284)
|
|
|
(4,284)
|
|
Repurchase of common stock (in shares) |
|
(1,977)
|
|
|
|
|
|
Repurchase of common stock |
(311,995)
|
|
(25,436)
|
(286,559)
|
|
(311,995)
|
|
Cash dividends and dividend equivalents declared |
(134,238)
|
|
|
(134,238)
|
|
(134,238)
|
|
Stock-based compensation expense |
31,270
|
|
31,270
|
|
|
31,270
|
|
Balance (in shares) at Mar. 31, 2020 |
|
155,049
|
|
|
|
|
|
Balance at Mar. 31, 2020 |
$ 2,325,196
|
|
$ 2,019,071
|
$ 376,656
|
$ (88,294)
|
$ 2,307,433
|
$ 17,763
|